- Posts: 652
- Thank you received: 20
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
www.ncbi.nlm.nih.gov/pmc/articles/PMC3296420/
J Pediatr Neurosci. 2011 Jul-Dec; 6(2): 160–161.
doi: 10.4103/1817-1745.92858 PMCID: PMC3296420
Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
K. Kaarthigeyan and Vasu V. Burli1
Dear Sir,
Intravenous immunoglobulin (IVIG) is a life-saving therapeutic agent, increasingly used to treat various immunological and hematological disorders. We encountered aseptic meningitis in an adolescent boy with immunodeficiency 10 days following IVIG therapy. This entity may be more prevalent than one would assume from the low number of reported cases. We report this due to its rarity and the need for recognition.
[...]
omcr.oxfordjournals.org/content/2014/7/132.full
Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
Rajendra Singh Jain, Sunil Kumar*, Rakesh Aggarwal and Jagdeesh Chandra Kookna
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
www.bloodjournal.org/content/124/21/5012.full.pdf
Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)
Francesco Iuliano, MD, Eleonora Iuliano, MD*, Maria Luci, MD*, Alessia Perricelli, MD*, Angelo Pomillo, MD*, and Elisabetta Abruzzese
Conclusion
Application of SCIG was well tolerated, easy to manage, and led to stabilization of the disease course.The therapy facilitates home therapy, as the infusion technique is easy for children, adults and elderly people to learn and there is no need for venous access. SCIG home therapy leads to significantly improved life situations for the patients; the SCIG home therapy regimen in particular reduces the costs of treatment. Overall costs per patient were strongly reduced in SCIG in comparison to IVIg.SCIG may represent an effective new therapeutic option in chronic ITP.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003 | pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.
© Copyright 1997 - 2026, Platelet Disorder Support Association. All rights reserved.
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.